Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hun Kang

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)|August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacementMi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve ReplacementYeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
European Heart Journal|August 31, 2025
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trialDo-Yoon Kang, Seong-Bong Wee, Jung-Min Ahn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 4, 2024
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trialHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
American Heart Journal|December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trialMijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
American Heart Journal|April 6, 2025
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trialJinho Lee, Han-Su Park, Junghoon Lee, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
BMJ Open|January 6, 2021
Rationale and design of the ADAPT-TAVR trial: a randomised comparison of edoxaban and dual antiplatelet therapy for prevention of leaflet thrombosis and cerebral embolisation after transcatheter aortic valve replacementHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
The American Journal of Cardiology|July 30, 2023
Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR TrialJeen Hwa Lee, Jung-Min Ahn, Do-Yoon Kang, et al.
Heart (British Cardiac Society)|August 16, 2023
Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacementMi Hee Jang, Jung-Min Ahn, Do-Yoon Kang, et al.
JACC. Cardiovascular Interventions|December 27, 2023
Frequency, Predictors, and Clinical Impact of Valvular and Perivalvular Thrombus After Transcatheter Aortic Valve ReplacementYeonwoo Choi, Jung-Min Ahn, Do-Yoon Kang, et al.
Circulation|April 4, 2022
Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical TrialDuk-Woo Park, Jung-Min Ahn, Do-Yoon Kang, et al.
European Heart Journal|August 31, 2025
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trialDo-Yoon Kang, Seong-Bong Wee, Jung-Min Ahn, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 4, 2024
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trialHanbit Park, Do-Yoon Kang, Jung-Min Ahn, et al.
American Heart Journal|December 20, 2023
Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trialMijin Kim, Jung-Min Ahn, Do-Yoon Kang, et al.
American Heart Journal|April 6, 2025
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROTECT- HBR trialJinho Lee, Han-Su Park, Junghoon Lee, et al.
Pageof 8